In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2663-2666

  Stone, Gregory G ^a,c   Girard, Dennis ^a   Finegan, Steve ^a   Duignan, Joan ^a   Schafer, John ^a   Maloney, Meghan ^a   Zaniewski, Richard P ^a   Brickner, Steven J ^a   Wade, Sarah K ^a   Le, Phuong T ^a   Huband, Michael D ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b PFIZER INC   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORO 2 CYCLOPROPYLETHYL DERIVATIVE; CE 156811; CEFTAZIDIME; CYCLOPROPANE DERIVATIVE; DALFOPRISTIN PLUS QUINUPRISTIN; FURANOSE; HYGROMYCIN; LEVOFLOXACIN; LINEZOLID; POLYSACCHARIDE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; DRUG SCREENING; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTIDRUG RESISTANCE; NEISSERIA; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CINNAMATES; DIOXOLES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; HYGROMYCIN B; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; OXAZOLIDINONES;

EID: 46249096898     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01326-07     Document Type: Article

References (11)

1. Bassetti, M., G. Melica, A. Di Biagio, E. Righi, R. Rosso, and D. Bassetti. 2004. New antibiotics for treatment of serious infections due to antibiotic-resistant gram-positive cocci. Rev. Med. Microbiol. 15:109-117.
2. Guerrero, M. D., and J. Modolell. 1980. Hygromycin A, a novel inhibitor of ribosomal peptidyltransferase. Eur. J. Biochem. 107:409-414.
3. Hecker, S. J., C. B. Cooper, and K. T. Blair. 1993. Semisynthetic modification of hygromycin A. 2. Synthesis and antibacterial activity of Aryl Analogs. Bioorg. Med. Chem. Lett. 3:289-294.
4. Huband, M. D., et al. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-1963.
5. Levy, S. B., and B. Marshall. 2004. Antibacterial resistance worldwide: causes, challenges, and responses. Nat. Med. 10:S122-S129.
6. Mann, R. L., R. M. Gale, and R. F. Van Aberlee. 1953. Hygromycin II. Isolation and properties. Antibiot. Chemother. 3:1279-1282.
7. Murray, R., E. Melchior, J. Hagadorn, and K. Marotti. 2001. Staphylococcus aureus cell extract transcription-translation assay: firefly luciferase system for evaluating protein inhibitors. Antimicrob. Agent. Chemother. 45:1900-1904.
8. National Committee for Clinical and Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 6th ed. (M7-A6). National Committee for Clinical and Laboratory Standards, Wayne, PA.
9. Norrby, R. S., C. E. Nord, and R. Finch. 2005. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. 5:115-119.
10. Pittenger, R. C., R. N. Wolfe, P. N. Hoehn, W. A. Daily, and J. M. McGuire. 1953. Hygromycin. I. Preliminary studies in the production and biologic activity on a new antibiotic. Antibiot. Chemother. 3:1268-1278.
11. Stone, G. G., et al. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-1962.